earnings
IM
NASDAQ · IMTX
Immatics N.V.
Healthcare · Biotechnology
$9.09
Down-$0.16 (-1.73%)
Updated Aug 19, 2026, 12:00 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.22B
- P/E ratio
- -8.99
- Dividend yield
- 0.00%
- 52-week range
- $5.05 – $12.41
- Volume
- 995.02K
- Avg. volume
- 800.14K
Price performance
IMTX price history
1M range · 21 trading sessions · Daily adjusted prices
IMTX closed at $9.09 after 21 trading sessions, down 3.40% for the selected period.
- Last close
- $9.09
- Period change
- -3.40%
- Period low
- $8.63
- Period high
- $9.77
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $9.06 | $9.29 | $8.83 | $9.09 | 995.02K |
| Aug 17, 2026 | $9.37 | $9.56 | $9.20 | $9.25 | 1.07M |
| Aug 14, 2026 | $9.68 | $9.68 | $9.39 | $9.44 | 362.69K |
| Aug 13, 2026 | $9.71 | $9.98 | $9.535 | $9.59 | 284.2K |
| Aug 12, 2026 | $9.79 | $9.91 | $9.59 | $9.71 | 188.42K |
| Aug 11, 2026 | $9.76 | $9.86 | $9.52 | $9.75 | 264.41K |
| Aug 10, 2026 | $9.66 | $9.86 | $9.60 | $9.72 | 240.64K |
| Aug 7, 2026 | $9.56 | $9.91 | $9.475 | $9.65 | 309.3K |
| Aug 6, 2026 | $9.86 | $9.8711 | $9.38 | $9.42 | 320.96K |
| Aug 5, 2026 | $9.40 | $9.79 | $9.16 | $9.77 | 676.49K |
| Aug 4, 2026 | $9.08 | $9.415 | $9.045 | $9.38 | 442.27K |
| Aug 3, 2026 | $8.62 | $9.055 | $8.37 | $9.02 | 257.48K |
| Jul 31, 2026 | $9.20 | $9.20 | $8.575 | $8.66 | 213.1K |
| Jul 30, 2026 | $9.05 | $9.57 | $8.915 | $9.20 | 1.61M |
| Jul 29, 2026 | $8.68 | $9.11 | $8.51 | $8.99 | 433.92K |
| Jul 28, 2026 | $8.56 | $8.75 | $8.17 | $8.735 | 535.04K |
| Jul 27, 2026 | $9.19 | $9.45 | $8.61 | $8.63 | 453.19K |
| Jul 24, 2026 | $9.32 | $9.32 | $9.01 | $9.08 | 290.49K |
| Jul 23, 2026 | $9.02 | $9.4075 | $9.00 | $9.29 | 352.46K |
| Jul 22, 2026 | $9.265 | $9.50 | $9.07 | $9.17 | 249.73K |
| Jul 21, 2026 | $9.23 | $9.475 | $9.22 | $9.41 | 157.47K |
Latest IMTX news
The latest Smart Investors Daily articles mentioning IMTX.
Stock researchResearch & News · Competitors
Loading stock research…